Genenta Science S.p.A.
GNTA
$1.60
-$0.20-11.11%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -17.59% | -13.86% | -8.91% | -8.42% | -5.80% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -29.41% | -19.61% | -8.26% | -13.94% | -16.74% |
| Operating Income | 29.41% | 19.61% | 8.26% | 13.94% | 16.74% |
| Income Before Tax | 23.89% | 13.56% | 2.00% | 15.20% | 23.43% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 23.89% | 13.56% | 2.00% | 15.20% | 23.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.89% | 13.56% | 2.00% | 15.20% | 23.43% |
| EBIT | 29.41% | 19.61% | 8.26% | 13.94% | 16.74% |
| EBITDA | 29.39% | 19.59% | 8.22% | 13.97% | 16.81% |
| EPS Basic | 28.79% | 16.70% | 3.40% | 15.94% | 23.68% |
| Normalized Basic EPS | 28.78% | 16.64% | 3.36% | 15.89% | 23.66% |
| EPS Diluted | 28.79% | 16.70% | 3.40% | 15.94% | 23.68% |
| Normalized Diluted EPS | 28.78% | 16.64% | 3.36% | 15.89% | 23.66% |
| Average Basic Shares Outstanding | 7.86% | 4.74% | 1.60% | 0.96% | 0.31% |
| Average Diluted Shares Outstanding | 7.86% | 4.74% | 1.60% | 0.96% | 0.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |